Evidence map›Paper›PMID 25927914›Full record

ArticleSystematic reviews2015

The impact of chronic pain on opioid addiction treatment: a systematic review protocol.

Brittany B Dennis, Monica Bawor, James Paul, Michael Varenbut, Jeff Daiter, Carolyn Plater, Guillaume Pare, David C Marsh, Andrew Worster, Dipika Desai and 2 more

Open access · goldAbstract read
In one paragraph

Article in Systematic reviews, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Brittany B DennisDepartment of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, Ontario, L8S4L8, Canada. dennisbb@mcmaster.ca.
Monica BaworPopulation Genomics Program, Chanchlani Research Centre, 1280 Main Street West, Hamilton, Ontario, L8S4L8, Canada. baworm@mcmaster.ca.
James PaulDepartment of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, Ontario, L8S4L8, Canada. paulj@mcmaster.ca.
Michael VarenbutCanadian Addiction Treatment Centres, 13291 Yonge St #403, Richmond, Hill, Ontario, L4E4L6, Canada. mvarenbut@canatc.ca.
Jeff DaiterCanadian Addiction Treatment Centres, 13291 Yonge St #403, Richmond, Hill, Ontario, L4E4L6, Canada. jdaiter@canatc.ca.
Carolyn PlaterCanadian Addiction Treatment Centres, 13291 Yonge St #403, Richmond, Hill, Ontario, L4E4L6, Canada. cplater@toxpro.ca.
Guillaume PareDepartment of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, Ontario, L8S4L8, Canada. pareg@mcmaster.ca.
David C MarshCanadian Addiction Treatment Centres, 13291 Yonge St #403, Richmond, Hill, Ontario, L4E4L6, Canada. dmarsh@nosm.ca.
Andrew WorsterCanadian Addiction Treatment Centres, 13291 Yonge St #403, Richmond, Hill, Ontario, L4E4L6, Canada. worster@mcmaster.ca.
Dipika DesaiPopulation Genomics Program, Chanchlani Research Centre, 1280 Main Street West, Hamilton, Ontario, L8S4L8, Canada. dipika.desai@phri.ca.
Lehana ThabaneDepartment of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, Ontario, L8S4L8, Canada. thabanl@mcmaster.ca.
Zainab SamaanDepartment of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, Ontario, L8S4L8, Canada. samaanz@mcmaster.ca.
McMaster University · CA

Funding

Canadian Institutes of Health Research 126639
6 · The paper itself

Abstract

backgroundThe consequences of opioid relapse among patients being treated with opioid substitution treatment (OST) are serious and can result in abnormal cardiovascular function, overdose, and mortality. Chronic pain is a major risk factor for opioid relapse within the addiction treatment setting. There exist a number of opioid maintenance therapies including methadone, buprenorphine, naltrexone, and levomethadyl acetate (LAAM), of which the mediating effects of pain on treatment attrition, substance use behavior, and social functioning may differ across therapies. We aim to 1) evaluate the impact of pain on the treatment outcomes of addiction patients being managed with OST and 2) identify the most recently published opioid maintenance treatment guidelines from the United States, Canada, and the UK to determine how the evidence is being translated into clinical practice. METHODS/

designThe authors will search Medline, EMBASE, PubMed, PsycINFO, Web of Science, Cochrane Database of Systematic Reviews, ProQuest Dissertations and theses Database, Cochrane Central Register of Controlled Trials (CENTRAL), World Health Organization International Clinical Trials Registry Platform Search Portal, and the National Institutes for Health Clinical Trials Registry. We will search www. GUIDELINES: gov and the National Institute for Care and Excellence (NICE) databases to identify the most recently published OST guidelines. All screening and data extraction will be completed in duplicate. Provided the data are suitable, we will perform a multiple treatment comparison using Bayesian meta-analytic methods to produce summary statistics estimating the effect of chronic pain on all OSTs. Our primary outcome is substance use behavior, which includes opioid and non-opioid substance use. We will also evaluate secondary endpoints such as treatment retention, general physical health, intervention adherence, personal and social functioning, as well as psychiatric symptoms. DISCUSSION: This review will capture the experience of treatment outcomes for a sub-population of opioid addiction patients and provide an opportunity to distinguish the best quality guidelines for OST. If chronic pain truly does result in negative consequences for opioid addiction patients, it is important we identify which OSTs are most appropriate for chronic pain patients as well as ensure the treatment guidelines incorporate this information. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42014014015 http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42014014015#.VS1Qw1wkKGM.

Indexed as

Chronic PainOpiate Substitution TreatmentAnalgesics, OpioidClinical ProtocolsHumansOpioid-Related DisordersRecurrenceResearch DesignSystematic Reviews as TopicAnalgesics, Opioid

Identifiers

PMID25927914
PMCPMC4403999
OpenAlexW2103146910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.